Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2021 应如何在神经性厌食症的干预中将同情心表现为主要的临床和伦理价值观? Melissa Lavoie(医学博士) and Angela S. Guarda(医学博士) AMA J Ethics. 2021;E298-304. doi: 10.1001/amajethics.2021.298. Case and Commentary Apr 2021 How Should Compassion Be Expressed as a Primary Clinical and Ethical Value in Anorexia Nervosa Intervention? Melissa Lavoie, MD and Angela S. Guarda, MD For an adolescent patient with extreme anorexia nervosa, steps for expressing compassion during a force intervention need to be clear. AMA J Ethics. 2021;23(4):E298-304. doi: 10.1001/amajethics.2021.298. Case and Commentary Apr 2021 ¿De qué forma debería expresarse la compasión como un valor clínico y ético primario en una intervención por anorexia nerviosa? Melissa Lavoie, MD and Ángela S. Guarda, MD AMA J Ethics. 2021;E298-304. doi: 10.1001/amajethics.2021.298. Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924. Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138. Case and Commentary Feb 2019 Should Watson Be Consulted for a Second Opinion? David D. Luxton, PhD, MS Guidance for organizations using AI tools to diagnose and to develop treatment recommendations can also help clinicians consider risks and benefits. AMA J Ethics. 2019;21(2):E131-137. doi: 10.1001/amajethics.2019.131. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary Apr 2023 How Should Food Offered by Health Care Organizations Meet Individual, Community, and Ecological Needs? Jennifer L. Weinberg, MD, MPH, MBE Sustainable food services are key dimensions of health care organizations’ civic and stewardship responsibilities to individuals and communities. AMA J Ethics. 2023;25(4):E256-263. doi: 10.1001/amajethics.2023.256. Case and Commentary Mar 2005 An Adolescent with an Eating Disorder Garry Sigman, MD Virtual Mentor. 2005;7(3):213-217. doi: 10.1001/virtualmentor.2005.7.3.ccas2-0503. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Apr 2021 应如何在神经性厌食症的干预中将同情心表现为主要的临床和伦理价值观? Melissa Lavoie(医学博士) and Angela S. Guarda(医学博士) AMA J Ethics. 2021;E298-304. doi: 10.1001/amajethics.2021.298.
Case and Commentary Apr 2021 How Should Compassion Be Expressed as a Primary Clinical and Ethical Value in Anorexia Nervosa Intervention? Melissa Lavoie, MD and Angela S. Guarda, MD For an adolescent patient with extreme anorexia nervosa, steps for expressing compassion during a force intervention need to be clear. AMA J Ethics. 2021;23(4):E298-304. doi: 10.1001/amajethics.2021.298.
Case and Commentary Apr 2021 ¿De qué forma debería expresarse la compasión como un valor clínico y ético primario en una intervención por anorexia nerviosa? Melissa Lavoie, MD and Ángela S. Guarda, MD AMA J Ethics. 2021;E298-304. doi: 10.1001/amajethics.2021.298.
Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924.
Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138.
Case and Commentary Feb 2019 Should Watson Be Consulted for a Second Opinion? David D. Luxton, PhD, MS Guidance for organizations using AI tools to diagnose and to develop treatment recommendations can also help clinicians consider risks and benefits. AMA J Ethics. 2019;21(2):E131-137. doi: 10.1001/amajethics.2019.131.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary Apr 2023 How Should Food Offered by Health Care Organizations Meet Individual, Community, and Ecological Needs? Jennifer L. Weinberg, MD, MPH, MBE Sustainable food services are key dimensions of health care organizations’ civic and stewardship responsibilities to individuals and communities. AMA J Ethics. 2023;25(4):E256-263. doi: 10.1001/amajethics.2023.256.
Case and Commentary Mar 2005 An Adolescent with an Eating Disorder Garry Sigman, MD Virtual Mentor. 2005;7(3):213-217. doi: 10.1001/virtualmentor.2005.7.3.ccas2-0503.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.